DRUGBright Minds Biosciences Inc.
Price
-16%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
A flag to check, growing in the filings, the market against it.
- Businessn/a
- SafetyWatch
- Valuationn/a
- GrowthGood
- MarketWatch
Bright Minds Biosciences Inc. (the "Company" or "Bright Minds") is a "foreign private issuer" as defined in Rule 3b-4 under Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is a Canadian issuer eligible to file its annual report ("Annual Report") pursuant to Section 13 of the Exchange Act on Form 40-F pursuant to the multi-jurisdictional disclosure system (the "MJDS") adopted by the United States Securities and Exchange Commission (the "SEC").
In the company’s own words · 40-F filed Dec 23, 2025 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
For the full year FY2025, revenue was CAD 1.5M (+4943% year on year) and net income −CAD 12M.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.